Abbott Laboratories (NYSE:ABT) Updates FY 2024 Earnings Guidance
Abbott Laboratories (NYSE:ABT – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 4.640-4.700 for the period, compared to the consensus EPS estimate of 4.660. The company issued revenue guidance of -. Abbott Laboratories also updated its Q4 guidance to $1.31-1.37 EPS. Analyst Ratings Changes Several equities […]
More Stories
Napco Security Technologies, Inc. (NASDAQ:NSSC) Stock Position Boosted by Laurus Investment Counsel Inc.
Laurus Investment Counsel Inc. boosted its stake in Napco Security Technologies, Inc. (NASDAQ:NSSC – Free Report) by 40.2% in the...
Strategic Advocates LLC Acquires 62,428 Shares of iShares 1-5 Year Investment Grade Corporate Bond ETF (NASDAQ:IGSB)
Strategic Advocates LLC boosted its holdings in shares of iShares 1-5 Year Investment Grade Corporate Bond ETF (NASDAQ:IGSB – Free...
Strategic Advocates LLC Purchases 2,809 Shares of AppLovin Co. (NASDAQ:APP)
Strategic Advocates LLC lifted its position in AppLovin Co. (NASDAQ:APP – Free Report) by 29.3% during the 3rd quarter, according...
OmniStar Financial Group Inc. Invests $379,000 in FormFactor, Inc. (NASDAQ:FORM)
OmniStar Financial Group Inc. bought a new position in FormFactor, Inc. (NASDAQ:FORM – Free Report) in the third quarter, HoldingsChannel...
OmniStar Financial Group Inc. Buys Shares of 5,427 Prudential Financial, Inc. (NYSE:PRU)
OmniStar Financial Group Inc. bought a new stake in shares of Prudential Financial, Inc. (NYSE:PRU – Free Report) during the...
OmniStar Financial Group Inc. Acquires New Stake in Sealed Air Co. (NYSE:SEE)
OmniStar Financial Group Inc. acquired a new stake in Sealed Air Co. (NYSE:SEE – Free Report) in the third quarter,...